C4 Therapeutics Inc. (CCCC)
NASDAQ · Healthcare
C4 Therapeutics Inc. annual/quarterly long term debt history from 2021 to 2022. Long term debt refers to financial obligations that are due more than one year in the future.
- C4 Therapeutics Inc. long term debt for the quarter ending December 31, 2022 were 11.5M, a 6.63% increase year-over-year.
- C4 Therapeutics Inc. long term debt for 2022 were 11.5M, a 6.63% increase from 2021.
- C4 Therapeutics Inc. long term debt for 2021 were 10.8M.
Long Term Debt
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| C4 Therapeutics Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2022 | $11 |
| 2021 | $11 |
| C4 Therapeutics Inc. Quarterly Long Term Debt (Millions of US $) | |
|---|---|
| 2022-12-31 | $11 |
| 2021-12-31 | $11 |
C4 Therapeutics Inc. Long Term Debt — FAQ
C4 Therapeutics Inc. (CCCC) long term debt over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CCCC's long term debt history?
The chart and table above show C4 Therapeutics Inc.'s long term debt by year and by quarter, including the growth rate.